FIRE Study Approved

31 Jul 2017

A new study now approved to be launched internationally headed up by Professor Stricker for the treatment of failed radiotherapy using NanoKnife ablation (FIRE study).

This study which is an international, multicentre study headed up by Professor Stricker involving centres such as the Sloan-Kettering in New York, University College Hospital in London, Amsterdam Cancer Centre in the Netherlands and the Centre in New Zealand will be now accruing patients to assess the success rate of focal NanoKnife ablation which is a minimally invasive treatment in patients who have failed radiotherapy in their prostate. This is registered online and the first centre to be open for accrual is Professor Stricker's centre in St Vincent's with 50 patients to be treated in total and it is hoped that this will give another option for treatment in patients who have failed radiotherapy and also to be able to do it in a minimally invasive way.

Key aspects

From diagnosis and treatment to rehabilitation and research, I believe my highly experienced team and I bring a multifaceted approach to understanding and helping our patients. A summary of these key aspects of that approach is available here in PDF format. If you are suffering from prostate cancer or have reason to believe you might be, you are welcome to contact us or, intially, complete our comprehensive second opinion form.